Page 30 - ARNM-2-2
P. 30

Advances in Radiotherapy
            & Nuclear Medicine                                                     Generative AI enhances radiotherapy



            long-term  viability  of  CR  practices.  This  integration  not   eliminate any remaining cancer cells and reduce the risk of
            only advances the technical aspects of CR but also reflects   recurrence.  If used before surgery, it is termed neoadjuvant
                                                                        3
            a commitment to ethical and inclusive practices. The   therapy, with the goal of shrinking tumors and facilitating
            journey into this transformative intersection promises not   more effective surgical removal. 3
            only to refine treatment outcomes but also to redefine the   CR is used in the treatment of various types of cancer
            landscape of CR for the future.
                                                               (solid tumors or hematologic malignancies). CR is highly
              The primary objectives of this article are to explore and   effective in treating a wide range of solid tumors, including
            elucidate the multifaceted role of GAI and CS in optimizing   but not limited to breast cancer, lung cancer, prostate
            CR. The article aims to comprehensively examine    cancer, head-and-neck cancer, and gastrointestinal cancer.
                                                                                                             2
            how advanced artificial intelligence (AI) techniques   In addition, radiation therapy is used in the treatment
            (particularly  generative  models)  and CS principles  can   of hematologic malignancies, such as lymphomas and
            synergistically contribute to enhancing various facets   leukemias. 2
            of CR, including treatment planning, adaptation, and   There are two primary methods for delivering radiation
            resource optimization.
                                                               to the cancer site. External beam radiation is administered
              By investigating the potential applications and benefits   from outside the body by directing high-energy beams
            of  AI-driven  strategies  in  the  context  of  CR,  the  article   (photons, protons, or particle radiation) to the tumor
            seeks to provide insights into the transformative impact   location, representing the most common approach in
            of these technologies on the precision, efficiency, and   the clinical setting.  Conversely, internal radiation, or
                                                                               4
            sustainability of radiotherapy treatments. In addition, the   brachytherapy, involves the delivery of radiation from
            article endeavors to identify potential challenges and ethical   inside the body using radioactive sources, which are
            considerations, fostering a comprehensive understanding   sealed in catheters or seeds directly at the tumor site.
            of the integration of AI and CS in the field of CR.  Brachytherapy is particularly used in routine treatment as
                                                               well as in situations where retreatment is indicated, due to
            2. Conceptualization                               its short-range effects. 5
            2.1. CR                                              CR  remains a  critical  and versatile  tool in  cancer

            CR plays a crucial role in cancer treatment and is a   treatment, serving as either a primary treatment or
            cornerstone of the multidisciplinary approach to managing   adjuvant therapy. Its significance is underscored by its
            various types of cancers.  This therapeutic modality utilizes   ability to control or eliminate tumors, contribute to a
                               1
            ionizing radiation to target and destroy cancer cells, with   multidisciplinary  approach,  and  improve  the  overall
            the primary objective of either eliminating the tumor or   prognosis and quality of life for cancer patients.
            controlling its growth. 2
                                                               2.2. GAI
              CR can be used with the intention of cure, for disease
            control, for local tumor control, or in combination with   GAI refers to a category of AI systems and models capable
                                                               of autonomously generating new, original content. Unlike
            other treatments.  In cases of curative intent where the   traditional AI models, which primarily focus on tasks,
                          2
            cancer  is  localized,  CR  aims  at  completely  eradicating   such as classification or prediction, generative models are
            cancer cells and achieving long-term remission. In
            controlling the disease (in metastatic or advanced cases),   specifically designed to create novel data, including images,
                                                                                            6
            CR can be employed to control tumor growth, relieve   text, music, or other forms of content.  These developments
            symptoms, and prolong survival. As a local tumor control,   in AI have enabled new paradigms of machine processing,
            CR is often employed as a primary treatment modality   shifting from data-driven, discriminative AI tasks toward
                                                               sophisticated and creative tasks through GAI.
                                                                                                   7
            for localized tumors, aiming to eradicate cancer cells
            within the target area, preventing further growth and   AI encompasses various computational techniques
            potential spread to adjacent tissues.  It can also be used in   capable of undertaking tasks typically associated with
                                        2
            combination with other treatments as part of a multimodal   human intelligence, such as comprehending natural
            approach, combining it with surgery, chemotherapy, and   language,  identifying  patterns,  making  decisions,  and
            immunotherapy.  This comprehensive approach aims to   learning from experience. 8
                         3
            address cancer at different levels and stages.       A subset of AI, machine learning, involves the
              Combined with surgery, CR can be characterized as   development of algorithms that can autonomously handle
            adjuvant or neoadjuvant therapy. If used after surgery, it   tasks by learning from data without explicit programming.
                                                                                                             9
            is termed adjuvant therapy; in this case, radiation aims to   Within machine learning, different approaches exist,

            Volume 2 Issue 2 (2024)                         2                              doi: 10.36922/arnm.3523
   25   26   27   28   29   30   31   32   33   34   35